Tag
- Pfizer's paxlovid reduces the risk of COVID-19 by 26% 2022-11-07
- The battle between Pfizer and Gilead over COVID-19 drugs wil... 2022-11-03
- 1200 cases were newly prescribed by Junshi Biologic for mild... 2022-10-24
- Twenty-five COVID-19 Vaccines In China Enter Stages Of Clini... 2022-06-09
- Pfizer to Increase Production Capacity of COVID-19 Oral Drug... 2022-06-08
- Anke Bio and Afana Collaborate on mRNA Vaccines for Mutant S... 2022-05-17
- As Low as $25/session! Pfizer's COVID-19 Oral Drug Paxlovid ... 2022-05-16
- Survey On Corona Deaths By Country 2022-05-09
- COVID-19 Drug Remdesivir Approved for Infants And Young Chil... 2022-04-28
- Roche's Q1 Performance Increases by 10%, And Total Revenue f... 2022-04-26
Market Analysis
- BDO Market Conditions Remain Weak, Pending Further Observations Feb-07,2026
- This Week's Isopropanol Market Prices First Increased Then Decreased (2.2-2.6) in China Feb-07,2026
- Ethanol Market Remains at High Levels with Consolidation Feb-07,2026
- Negative Factors Weighing Down, Palm Oil Prices Weak and Declining Feb-07,2026
- This Week's Activated Carbon Prices Rose (2.2-2.6) in China Feb-07,2026